HELIXPACE evaluates DNA integrity and the efficiency of cellular repair mechanisms. Chronic inflammation, oxidative stress, and exposure to genotoxic agents can compromise DNA repair processes, leading to accumulation of genetic damage and increased genomic instability. This test analyses germinal and somatic mutations in key genes, identifying genotoxic damage and assessing the body's capacity to maintain genomic integrity. Progressive accumulation of mutations in tumour suppressor genes and driver genes is associated with accelerated aging and increased risk of degenerative and oncological diseases.

SENEXPACE assesses cellular senescence, a defence mechanism that prevents the uncontrolled proliferation of cells with damaged DNA and high tumourigenic potential. However, senescent cells release inflammatory signals (known as the Senescence-Associated Secretory Phenotype - SASP) that generate and propagate inflammation throughout the body, triggering systemic inflammatory responses. When the immune system is weakened, senescent cells are not efficiently removed and progressively accumulate in tissues, perpetuating chronic inflammation and accelerating biological aging.

CYTOXPACE assesses key markers of systemic inflammation that, when altered, are associated with accelerated aging processes, increased genotoxicity, and genomic instability – conditions that significantly increase the risk of disease onset. The test evaluates a comprehensive cytokine profile including interleukins (IL-2, IL-4, IL-6, IL-10, IL-12, IL-17A), interferon-gamma (IFN-γ), tumour necrosis factor-alpha (TNF-α), and high-sensitivity C-reactive protein (hs-CRP). These biomarkers provide essential insights into the inflammatory status and its impact on cellular health.

GENOXPACE assesses blood levels of 8-OHdG (8-hydroxy-2'-deoxyguanosine), a molecule that reflects oxidative DNA damage caused by reactive oxygen species (ROS). Cellular senescence, genotoxicity, and systemic inflammation are closely interrelated. The progressive accumulation of oxidative DNA damage contributes to genomic instability, accelerated aging, and increased risk of degenerative and oncological diseases. Monitoring 8-OHdG levels provides critical insights into the genotoxic burden and the effectiveness of antioxidant defences.

IMMUNEXPACE evaluates the balance and functional efficiency of the immune system. The immune system contributes to the resolution of systemic inflammation primarily through the clearance of senescent cells, which sustain inflammatory processes by releasing specific signalling molecules. When the immune system is weakened, senescent cells are not efficiently removed and progressively accumulate in tissues, perpetuating chronic inflammation. This test assesses immune cell populations, function markers, and the senolytic response capacity, providing insights into the body's ability to maintain immune homeostasis.

NANOXPACE detects and quantifies the presence of nano- and microplastics in the bloodstream. The immune system recognises these foreign particles and initiates an immune response that contributes to a state of chronic inflammation. The progressive accumulation of nano/microplastics promotes genotoxicity and genomic instability, ultimately accelerating degenerative ageing processes. Recent scientific evidence links microplastic exposure to increased oxidative stress, inflammatory markers, and tissue damage in multiple organ systems.

GUTXPACE analyses the gut microbiome to identify and characterise the microorganisms present in the intestinal tract. The balance of intestinal bacteria is one of the main modulators of immune responses and systemic inflammation. Dysbiosis (microbial imbalance) can contribute to systemic inflammation through the production of pro-inflammatory metabolites and increased intestinal permeability. Gut health directly influences the effectiveness of the immune system, including its ability to clear senescent cells that drive systemic inflammation.

HELIXPAN is a test designed to detect genomic instability through a peripheral blood sample. This parameter is assessed by monitoring the frequency of mutations and represents a key indicator of the prodromal phase of solid tumours. The DNA extracted from the sample is sequenced using advanced Next Generation Sequencing (NGS) technologies. The subsequent bioinformatic analysis enables the identification of potential mutations in the genes under investigation. HELIXPAN investigates and quantifies the presence of mutations in both tumour suppressor genes and driver genes, with the aim of assessing their effectiveness in preserving genomic stability. When repeated over time, the test can reveal a progressive accumulation of somatic mutations, which would support the persistent inactivation of these genes and the resulting genomic instability.

CYTOBALANCE monitors pro-inflammatory cytokine levels to assess the body's inflammatory status. This comprehensive analysis evaluates key inflammatory mediators that, when chronically elevated, contribute to tissue damage, accelerated aging, and increased disease risk. By tracking cytokine profiles over time, CYTOBALANCE provides valuable insights into the effectiveness of anti-inflammatory interventions and lifestyle modifications, supporting personalised strategies for inflammation management and overall health optimisation.

MICROBALANCE provides a comprehensive assessment of gut and vaginal microbiome composition and balance. The microbiome plays a crucial role in immune regulation, nutrient metabolism, and protection against pathogens. Dysbiosis – an imbalance in microbial communities – is associated with systemic inflammation, metabolic disorders, and increased susceptibility to infections. MICROBALANCE identifies microbial imbalances and provides actionable insights for restoring optimal microbiome health through targeted interventions.

HELIXBALANCE monitors genome instability by assessing DNA damage markers and repair mechanism efficiency. Genomic instability is a hallmark of aging and a key factor in the development of degenerative diseases and cancer. This analysis evaluates the accumulation of genetic alterations over time, providing critical insights into the effectiveness of protective interventions and lifestyle factors that influence DNA integrity. Regular monitoring supports proactive strategies for maintaining genomic stability and reducing disease risk.

IMMUNEBALANCE provides a comprehensive analysis of immune system balance and functional efficiency. A well-regulated immune system is essential for defending against infections, clearing damaged cells, and preventing chronic inflammation. This assessment evaluates immune cell populations, functional markers, and the balance between pro-inflammatory and anti-inflammatory responses. IMMUNEBALANCE identifies immune dysregulation patterns and supports personalised interventions to restore optimal immune function and resilience.

MSC therapy for skin rejuvenation works by replacing damaged and aging fibroblasts and keratinocytes, while boosting your skin's natural production of collagen and elastin. Unlike Botox, fillers, or PRP that offer temporary cosmetic improvements, MSCs address the root cause of skin aging. Key benefits include: replacement of old, damaged cells with new, functional ones; stimulated collagen and elastin production from within; progressive results with brightness in 2 weeks, fine lines improvement in 4-6 weeks, deep wrinkles in 8-12 weeks; long-lasting regeneration that continues for 3-6+ months.

BREASTSKILL uses your own autologous fat enriched with expanded MSCs to achieve natural breast augmentation. This innovative approach eliminates the risks associated with synthetic implants while providing long-lasting, natural-looking results. Key benefits include: no foreign materials, no implants, no replacement needed; 80-90% volume retention thanks to MSC-enhanced vascularization; natural look and feel—completely biocompatible; no risk of capsular contracture or implant rupture.

Keloids form due to an abnormal immune response and chronic inflammation that triggers excessive collagen production. KELOSKILL uses MSCs' powerful anti-inflammatory and anti-fibrotic properties to address this root cause—something surgical excision and laser cannot do. Key benefits include: targeting the abnormal immune response causing keloid formation; anti-inflammatory and immunomodulatory action; prevention of recurrence—unlike surgery or laser which often make keloids worse; non-invasive with no side effects.

Hair loss stems from cellular exhaustion, microcirculation impairment, chronic inflammation, and oxidative stress. HAIRSKILL addresses all these root causes by replacing exhausted stem cells and creating the optimal environment for hair follicle recovery. Key benefits include: reactivation of dormant and miniaturized hair follicles; reduced scalp inflammation and improved blood supply; visible results after 2-4 months with continued improvement for 9-12 months; effective for androgenetic alopecia, alopecia areata, telogen effluvium, and more.

Vaginal aging causes dryness, loss of elasticity, thinning walls, and pH changes that affect quality of life. GYNSKILL uses MSCs to stimulate fibroblast activity, enhance angiogenesis, and rebuild the extracellular matrix—providing results that conventional treatments cannot match. Key benefits include: restored vaginal hydration and natural lubrication; rebuilt elasticity and tissue thickness; reduced dyspareunia (painful intercourse); decreased recurrent infections by restoring healthy pH balance.

MALESKILL uses autologous fat enriched with expanded MSCs for safe, effective penis enhancement. Unlike synthetic fillers that cause irregular texture and require maintenance, this one-time procedure offers permanent improvement with natural look and feel. Key benefits include: noticeable and stable increase in girth; no synthetic materials, no foreign body reactions; natural softness and uniformity without lumps or irregularities; improved skin quality and elasticity.

Peyronie's disease affects 3-9% of adult men, causing penile curvature, pain, and erectile dysfunction due to fibrous plaque formation. FIBROSKILL combines Collagenase (to dissolve the plaque) with MSCs (to regenerate healthy tissue)—the most advanced treatment available. Key benefits include: collagenase softens and dissolves scar tissue; MSCs provide anti-fibrotic and anti-inflammatory action; prevents further plaque formation and preserves penile length; minimally invasive—far less risky than surgery.

ORTHOSKILL harnesses the unique ability of Mesenchymal Stem Cells to differentiate into the specialized cells your musculoskeletal system needs: chondrocytes for cartilage, osteoblasts for bone, and tenocytes for tendons. Unlike treatments that merely mask pain, MSC therapy addresses the underlying tissue damage. Conditions treated include: osteoarthritis and degenerative arthrosis; cartilage lesions and osteochondral defects; tendon and ligament injuries; avascular necrosis (AVN); bone fractures with delayed healing.

Premature Ovarian Failure (POF) can devastate women's quality of life, causing hormonal imbalances, menopausal symptoms, and fertility challenges. OVOSKILL uses ultrasound-guided MSC injection directly into the ovaries to restore function where hormone replacement therapy can only manage symptoms. Symptoms addressed include: irregular or absent menstrual periods; hot flashes and night sweats; vaginal dryness and decreased libido; mood swings and sleep disturbances; infertility concerns.

Erectile dysfunction often stems from vascular, neurological, or tissue damage that medications can only temporarily overcome. ANDROSKILL uses MSCs' regenerative capabilities to address the root causes—restoring blood vessel function, supporting nerve healing, and reducing chronic inflammation. Conditions treated include: vasculogenic ED (blood flow issues); diabetic erectile dysfunction; post-prostatectomy ED; age-related erectile dysfunction.

As we age, our cardiovascular system, organs, and tissues progressively decline. AGESKILL delivers MSCs systemically via IV infusion, allowing them to reach and regenerate tissues throughout the body—providing comprehensive anti-aging benefits that topical or localized treatments cannot achieve. Benefits include: improved skin quality and tissue tone; reduction in joint pain and stiffness; enhanced memory and cognitive function; better mood and sleep quality; increased energy and vitality.

Xerostomia (chronic dry mouth) dramatically impacts quality of life—affecting eating, speaking, and oral health. Whether caused by radiation therapy, aging, or autoimmune conditions like Sjögren's syndrome, XEROSKILL treatment uses MSCs to regenerate damaged salivary gland tissue. Clinical results include: 42% increase in saliva production documented in studies; restoration of natural lubrication; improved oral health and reduced infection risk; enhanced ability to eat, speak, and swallow.

Empty Nose Syndrome (ENS) occurs when over-aggressive turbinate reduction surgery removes too much nasal tissue, leaving patients unable to sense airflow despite open airways. ENSKILL offers a regenerative approach to help restore nasal function where traditional treatments have failed. Symptoms addressed include: nasal dryness and crusting; paradoxical sensation of nasal obstruction; difficulty breathing despite open airways; decreased sense of smell; fatigue and sleep disturbances.

CARESKILL provides MSC-based supportive care for patients with chronic and degenerative conditions. While not a cure, MSC therapy offers powerful anti-inflammatory, immunomodulatory, and anti-fibrotic support that can significantly improve quality of life and slow disease progression. Conditions supported include: COPD; Multiple Sclerosis (MS); Liver Cirrhosis; Crohn's Disease; Idiopathic Pulmonary Fibrosis (IPF); Systemic Lupus Erythematosus (SLE); Spinal Cord Injury; Type 1 Diabetes; Heart Failure.

EXOSKIN harnesses the regenerative power of MSC exosomes to restore youthful skin from the cellular level. The treatment stimulates fibroblast activity, promotes collagen and elastin synthesis, and reduces oxidative stress that contributes to skin aging. Key benefits include: reduction of fine lines and wrinkles; improved skin elasticity and firmness; enhanced skin hydration and texture; reduced hyperpigmentation and age spots; accelerated healing post-aesthetic procedures.

EXOHAIR offers a breakthrough approach to hair loss by targeting the underlying causes at the follicular level. MSC exosomes activate dormant hair follicle stem cells, promote angiogenesis for improved nutrient delivery, and modulate inflammation that contributes to hair loss. Key benefits include: reactivation of dormant hair follicles; prolonged anagen (growth) phase of hair cycle; improved scalp vascularization; reduced inflammation associated with hair loss; thicker, stronger hair growth.

EXOJOINTS addresses osteoarthritis and joint degeneration through targeted exosome therapy that promotes cartilage repair and reduces joint inflammation. The treatment modulates immune responses and stimulates chondrocyte activity for improved joint function. Key benefits include: promotion of cartilage regeneration; reduction of joint inflammation and pain; improved joint mobility and function; slowed progression of degenerative joint disease; non-surgical alternative to joint replacement.

EXOMALE provides a regenerative approach to erectile dysfunction by promoting tissue repair, enhancing vascular function, and improving penile blood flow. The treatment addresses the underlying causes of ED rather than just managing symptoms. Key benefits include: improved erectile function and quality; enhanced penile blood flow and vascular health; tissue regeneration in erectile tissues; increased sexual satisfaction; long-lasting results without ongoing medication.

EXOFEMALE offers a non-surgical solution for vaginal rejuvenation, promoting tissue regeneration and restoring intimate wellness. The treatment addresses changes due to childbirth, menopause, or aging through natural cellular signaling. Key benefits include: improved vaginal tissue elasticity and tightness; enhanced natural lubrication; reduced symptoms of vaginal atrophy; improved urinary continence; enhanced sexual sensation and satisfaction.

EXOSPORT is designed for athletes and active individuals seeking to enhance performance, accelerate recovery, and prevent injuries. MSC exosomes promote muscle regeneration, reduce exercise-induced inflammation, and optimize tissue repair. Key benefits include: accelerated muscle recovery post-exercise; reduced inflammation and muscle soreness; enhanced endurance and energy metabolism; improved joint and tendon health; faster return to training after injury.

EXOAGEING provides a holistic approach to healthy longevity by addressing multiple aspects of aging simultaneously. Systemic exosome therapy targets skin rejuvenation, joint health, muscle preservation, cognitive function, and metabolic wellness. Key benefits include: multi-system anti-aging effects; improved skin appearance and vitality; enhanced joint and muscle function; cardiovascular and metabolic health support; reduced cellular senescence and "inflammaging".

LIPOSKILL SAVE offers adults the opportunity to bank their own mesenchymal stem cells derived from adipose (fat) tissue. Unlike perinatal banking, this service is available at any age, making it an excellent option for those who missed the cord blood banking opportunity. Adipose tissue is one of the richest sources of mesenchymal stem cells (ADSCs/ASCs) in the adult body. A small amount of fat—typically 20ml of lipoaspirate—contains millions of stem cells with powerful regenerative potential for aesthetic medicine, orthopedic regeneration, wound healing, sexual wellness therapies, and anti-aging protocols.

ULTRANIPT represents the most comprehensive non-invasive prenatal screening available, validated on 112,669 pregnancies—the largest clinical study worldwide. Available from week 10, it offers expanded detection of chromosomal abnormalities, microdeletions, and monogenic disorders. 5 test options available: DG (T21, T18, T13 + sex chromosomes + DiGeorge syndrome), 2.0 (+ 92 microdeletion syndromes), WIDE (+ 118+ abnormalities), OMNIPT 3.0 (+ 202 monogenic disorders), OMNIPT WIDE (up to 320+ abnormalities). Clinical interpretation included with every report.

G-TEST PRO analyzes fragments of fetal DNA (cfDNA) naturally present in the mother's bloodstream from week 10 of pregnancy. This non-invasive test screens for chromosomal abnormalities with >99% sensitivity and specificity for the main trisomies, posing zero risk to the pregnancy. 4 test options available: TRISOMIES (T21, T18, T13), XY (+ sex chromosome aneuploidies), DELETIONS (+ 26 microdeletion syndromes), WGA (+ all chromosome deletions/duplications + rare aneuploidies). Results delivered in 5-7 working days.

MYCARRIER is an Expanded Carrier Test using Next-Generation DNA Sequencing (NGS) to detect mutations in more than 1,200 genes associated with over 1,200 genetic diseases, with >99.9% sensitivity and specificity. Ideal before conception or during early pregnancy. 6 test versions available: MYCARRIER (10+ conditions), MYCARRIER PLUS (170+ conditions), MYCARRIER TOP (1,200+ conditions), plus specialized panels for Hemophilia A and Thalassemia. Fragile X Syndrome analysis is always included in all versions. Results include clinical interpretation by our genetics team.

NEONATEST is an expanded neonatal screening performed in the first days of life that can identify certain rare genetic diseases before they cause serious harm. Using Tandem Mass Spectrometry (MS/MS) and biochemical/biomolecular techniques, it detects inherited metabolic diseases caused by enzyme deficiencies. NEONATEST Standard screens 55 conditions, while NEONATEST Plus expands coverage to over 70 conditions including phenylketonuria (PKU), congenital hypothyroidism, cystic fibrosis, and many more. Sample collection requires just a few drops of blood from the newborn's heel.

NEONASEQ is a genetic test for expanded neonatal screening of diseases that can affect various body systems and organs. These are highly disabling, sometimes life-threatening diseases that can have serious consequences for the health of the newborn, especially if they are not identified and treated early. Thanks to next-generation DNA sequencing technology, it is now possible to take a small blood sample from the newborn’s heel as early as the first day of life and analyze it to identify more than 260 diseases. NEONASEQ can detect more than 10,000 genetic variants associated with endocrine, metabolic, immune system, neuromuscular, blood, auditory system diseases, and more. If properly diagnosed and treated, the prognosis for the newborn can be significantly improved, also helping to reduce the impact of the disease on the family.

Cord blood banking captures a unique biological resource available only at the moment of birth. The umbilical cord blood contains hematopoietic stem cells (HSCs) that can differentiate into all types of blood and immune cells—red blood cells, white blood cells, and platelets. Cord blood stem cells have been used in over 40,000 transplants worldwide to treat more than 80 diseases, including leukemias and lymphomas, bone marrow failure syndromes, inherited metabolic disorders, immune deficiencies, and hemoglobinopathies. Collection is completely safe, non-invasive, and painless for both mother and baby.

Cord tissue banking preserves a different population of stem cells—mesenchymal stem cells (MSCs)—found in the Wharton's jelly of the umbilical cord. These cells offer therapeutic potential that complements cord blood banking with powerful anti-inflammatory and immunomodulatory properties. Cord tissue MSCs have the ability to differentiate into bone, cartilage, fat, and muscle cells, with tissue repair and regeneration capabilities. They are the subject of extensive research and clinical trials for autoimmune diseases, neurological conditions, cardiovascular disease, and orthopedic injuries.